Time to move beyond glycosylated haemoglobin
R. I. G. Holt,
R. I. G. Holt
Endocrinology & Metabolism Unit, Developmental Origins of Health and Disease Division, School of Medicine, University of Southampton, Southampton and
Search for more papers by this author I. Gallen,
I. Gallen
Diabetes Centre, Wycombe Hospital, High Wycombe, Buckinghamshire, UK
Search for more papers by this author
R. I. G. Holt,
R. I. G. Holt
Endocrinology & Metabolism Unit, Developmental Origins of Health and Disease Division, School of Medicine, University of Southampton, Southampton and
Search for more papers by this author I. Gallen,
I. Gallen
Diabetes Centre, Wycombe Hospital, High Wycombe, Buckinghamshire, UK
Search for more papers by this author
First published: 21 June 2004
No abstract is available for this article.
References
- 1
Jeppsson JO,
Kobold U,
Barr J,
Finke A,
Hoelzel W,
Hoshino T et al.
Approved IFCC reference method for the measurement of HbA1c in human blood.
Clin Chem Lab Med
2002; 40: 78–89.
- 2
Hoelzel W,
Weykamp C,
Jeppsson JO,
Miedema K,
Barr JR,
Goodall I et al.
IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.
Clin Chem
2004; 50: 166–174.
- 3
Manley S,
John WG,
Marshall S.
Introduction of IFCC reference method for calibration of HbA1c: implications for clinical care.
Diabet Med
2004; 21: 673–676.
- 4
The Diabetes Control and Complications Trial Research Group.
The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.
N Engl J Med
1993; 329: 977–986.
- 5
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).
Lancet
1998; 352: 837–853.
- 6
Hanas R.
Psychological impact of changing the scale of reported HbA (1c) results affects metabolic control.
Diabetes Care
2002; 25: 2110–2111.
